Severe secondary postpartum hemorrhage 3 weeks after cesarean section: Alternative etiologies of uterine scar non-union

2007 ◽  
Vol 33 (3) ◽  
pp. 360-362 ◽  
Author(s):  
Fabrizio Pollio ◽  
Stefania Staibano ◽  
Marianna De Falco ◽  
Ugo Buonocore ◽  
Gaetano De Rosa ◽  
...  
Author(s):  
Yogita B. Gavit ◽  
Deepika Sharma

Secondary postpartum hemorrhage is rare and affect 0.23-3% of all pregnancies. It happens between 24 hours to 12 weeks of post-delivery. These postpartum hemorrhages occur more often during normal vaginal delivery only a small subset of postpartum hemorrhages occurs after cesarean section. Delayed postpartum hemorrhage is obstetrics emergencies that occurs following vaginal or cesarean delivery, in later condition may be caused by dehiscence of uterus incision after cesarean section which can lead to severe and fatal bleeding. We herein report a case of secondary postpartum hemorrhage after cesarean section.


2018 ◽  
Vol 9 (1) ◽  
pp. 23-25
Author(s):  
Surayea Bul Bul ◽  
Zobaida Sultana Susan ◽  
Raunak Jahan ◽  
Abu Nayeem ◽  
Farzana Rahman ◽  
...  

Background : Complications of pregnancy and childbirth have always been one of the leading causes of death and disability among women of reproductive age in developing countries .Globally, postpartum haemorrhage is the single most important cause of maternal death, accounting for about 25% of the total and claiming an estimated 1,50,000 lives annually. Among the postpartum hemorrhage, the primary postpartum hemorrhage is more prevalent, but sufferings from secondary postpartum hemorrhage have been emerging. With the rising trend of cesarean section rate, the incidence of secondary postpartum hemorrhage is also rising.Objective: The objectives of this study is to evaluate secondary postpartum hemorrhage cases following cesarean section and vaginal delivery with the aim of reducing the maternal mortality at child bearing age.Methods: This is a cross sectional observational study in the department of Obstetrics and Gynaecology, DMCH , by purposive sampling method. Total 100 cases of secondary PPH were observed during 1st January 2013 to 31 December 2013.Result: In this study, among the cases 67% were following cesarean section and 33% were following vaginal delivery, mean age of the patients were 29 year, parity ranges from 1 to 5. Regarding the outcome of secondary PPH, severe anaemia, anaemic heartfailure, renal failure and DIC were common in cesarean sections along with hazards of massive blood transfusion and jaundice. 7 patients were died in post cesarean cases and 2 died in post vaginal delivery cases. Causes of death were due to hemorrhagic shock & septicemia.Conclusion: In this is study, the rate of secondary PPH is 67% following cesarean section which is very much alarming . The outcome of secondary PPH following cesarean section is worse than vaginal delivery.J Shaheed Suhrawardy Med Coll, June 2017, Vol.9(1); 23-25


2013 ◽  
Vol 2013 ◽  
pp. 1-4 ◽  
Author(s):  
Ahmet Ozgur Yeniel ◽  
Ahmet Mete Ergenoglu ◽  
Ali Akdemir ◽  
Elmin Eminov ◽  
Fuat Akercan ◽  
...  

Uterine artery pseudoaneurysm is a rare but serious complication of cesarean section. If inadequately treated, it can lead to life-threatening postpartum hemorrhage. Herein, we report the case of a 28-year-old woman who developed secondary postpartum hemorrhage resulting from uterine artery pseudoaneurysm and cesarean scar dehiscence after cesarean section. Angiographic embolization is a safe and effective procedure for treating postpartum hemorrhage resulting from pseudoaneurysm in hemodynamically stable patients. However, uterine artery ligation may be the surgical procedure of choice for hemodynamically unstable patients when fertility preservation is desired.


Author(s):  
Alexis Svokos MD ◽  
Kendall Cunningham MD ◽  
Maranda Sullivan DO ◽  
Saif Ahmed MD

We present the case of a 26-year-old female who experienced secondary postpartum hemorrhage nine days after an uncomplicated elective repeat low transverse cesarean section. She was found to have a uterine pseudoaneurysm and underwent gel foam embolization of the right uterine artery. Subsequently, patient was diagnosed with pulmonary embolism on post-embolization day 3, and was initiated on anti-coagulation regimen.


2017 ◽  
Vol 1 (2) ◽  
pp. 100-107
Author(s):  
Yusrawati Yusrawati

Uterine arteriovenous malformations is rare case which cause secondary postpartum hemorrhage. This disor-der can cause massive and suddden vaginal bleeding. Despite of rare case, secondary arteriovenous malforma-tions can occur after a cesarean section. Patients who undergo uterine arteriovenous malformation generally have symptoms of menorrhagia or metrorrhagia after miscarriage, uterine surgery, including cesarean section, and curettage. In severe cases, this can lead to malformations of dyspnoea and heart failure. Management of AVM is by embolization, methotrexate treatment and hysterectomy depending on patient condition. Here reported a case of a patient aged 25 years with a diagnosis of P2H1, AUB ec AVM. Patients got history of caesarean section 6 months ago, and since 5 months ago patients were admitted 8 times for recurrent bleed-ing. Diagnostic examinations found AVM and hysterectomy was done. The AUB diagnosis in patients is less precise, the patient should be diagnosed with secondary postpartum hemorrhage due to uterine arteriovenous malformation acquired. Uterine arteriovenous malformation diagnosis should be considered in patients with secondary postpartum haemorrhage.Keywords: arteriovenous malformation, a former cesarean section, AUB


2021 ◽  
Vol 13 (1) ◽  
Author(s):  
Nevein Gerges Fahmy ◽  
Fahmy Saad Latif Eskandar ◽  
Walid Albasuony Mohammed Ahmed Khalil ◽  
Mohammed Ibrahim Ibrahim Sobhy ◽  
Amin Mohammed Al Ansary Amin

Abstract Background Postpartum hemorrhage (PPH) is one of the leading causes of maternal mortality and morbidity worldwide. It is believed that hemostatic imbalance secondary to release of tissue plasminogen activator (tPA) and subsequent hyperfibrinolysis plays a major role in PPH pathogenesis. Antifibrinolytic drugs such as tranexamic acid (TXA) are widely used in hemorrhagic conditions associated with hyperfibrinolysis. TXA reduced maternal death due to PPH and its use as a part of PPH treatment is recommended, and in recent years, a number of trials have investigated the efficacy of prophylactic use of TXA in reducing the incidence and the severity of PPH. The study is aiming to assess the efficacy of tranexamic acid in reducing blood loss throughout and after the lower segment cesarean section and reducing the risk of postpartum hemorrhage. Results The amount of blood loss was significantly lower in the study group than the control group (416.12±89.95 and 688.68±134.77 respectively). Also the 24-h postoperative hemoglobin was significantly higher in the study group (11.66±0.79 mg/dl) compared to the control group (10.53±1.07mg/dl), and the 24-h postoperative hematocrit value was significantly higher in the study group (34.99±2.40) compared to control (31.62±3.22). Conclusion Prophylactic administration of tranexamic acid reduces intraoperative and postoperative bleeding in cesarean section and the incidence of postpartum hemorrhage.


2020 ◽  
Vol 48 (8) ◽  
pp. 853-855
Author(s):  
Abdul Rouf Pallivalapila ◽  
Isaac A. Babarinsa ◽  
Mariam Al-Baloushi ◽  
Ahmed Moursi ◽  
Arabo Bayo ◽  
...  

AbstractObjectivesThe objectives of this study were to quantify the prescription of oral methergin tablets in a busy Women’s Hospital, assess the stated indications for such prescription and highlight the issues and safety profile of Methergin use especially in the postpartum patient.MethodsReview of prescription data for oral Methergin and the corresponding annual figures on primary and secondary postpartum hemorrhage.ResultsOver a period of 5 years, oral Methergin prescriptions for delayed and secondary postpartum hemorrhage constituted less than 1% of the overall prescription in Obstetrics and Gynaecology, which ranged between 1214 and 2085 per year. The numbers were too few to ascertain any relationship with both types of postpartum hemorrhage. Although stated on the relevant Patient Information leaflet, no local or regional guideline on its use exist.ConclusionsSpecific and random trend monitoring of medications for continuing safety profile, risk benefit issues, or unapproved indication, may help in identifying, preventing and mitigating any medication safety matters. Clinical pharmacists in collaboration with physicians are well placed in conducting such pharmacovigilance activities to improve medication safety.


Sign in / Sign up

Export Citation Format

Share Document